Abstract：
Pulmonary hypertension (PH) is a medical condition characterized by elevated pulmonary vascular resistance and pressure, resulting from different diseases. Due to their high occurrence of PH, intricate hemodynamic classification, and frequently multifactorial cause and mechanism, individuals suffering from chronic kidney disease (CKD) are categorized as the fifth primary group of PH. Based on both domestic and international research, this article provides information on the epidemiology, risk factors, pathogenesis, and targeted drug treatment of PH associated with CKD.
摘要：
肺动脉高压（PH）是一种以肺血管阻力和压力升高为特征的医学疾病，由于不同的疾病。由于它们的高PH发生率，复杂的血液动力学分类，经常是多因素的原因和机制，患有慢性肾脏病(CKD)的个体被归类为PH的第五主要组。在国内外研究的基础上,这篇文章提供了关于流行病学的信息，危险因素，发病机制，和靶向药物治疗与CKD相关的PH。
